Technology | April 26, 2010

Closure Device Uses Single Suture, Steel Ring

Quick-Close Suture Applier


April 26, 2010 – A vascular closure device using a single suture fitted with stainless steel rings was recently cleared by the U.S. Food and Drug Administration (FDA)

The Quick-Close Vascular Suturing System from Interventional Therapies LLC ?is used to stop the bleeding of a puncture site following an interventional procedure using the femoral artery. It consists of the Quick-Close Suture Applier and the Quick-Ti Cinch Applier. The suture applier has a pistol grip shape and contains a single strand of an artificial suture (polybutester Novafil) fitted with stainless steel rings. The clinch applier has a syringe-type shape with an extended handle.

The suture applier is used to gain access to the puncture site. Using manual control, and relying on the sense of touch, the device is used to place one end of the suture through one edge of the arterial wound. The suture applier is then repositioned and the other end of the suture is inserted through the opposite edge of the wound site. As the suture applier is withdrawn from the wound, a 24-inch length of suture is forced out of its housing. The suture applier places a single stitch of a nonabsorbable, single thread suture to the wound site. The cinch applier gathers the two ends of the suture and then it places a stainless steel ring that acts in place of a knot to secure the suture in a closed position to stop the bleeding.

It is designed for use in vascular punctures with diameters of 4 mm or larger.
The device allows patients to become mobile sooner than is possible with standard compression methods.

For more information: www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances


Related Content

News | Hemostasis Management

October 27, 2021 — Teleflex Inc. announced the completion of patient enrollment in a clinical study evaluating the ...

Home October 27, 2021
Home
News | Hemostasis Management

April 21, 2021 — EnsiteVascular announced it received its second U.S. Food and Drug Administration (FDA) market ...

Home April 21, 2021
Home
Feature | Hemostasis Management | Dave Fornell, Editor

While many cardiac and vascular procedures have largely moved to minimally invasive techniques, the size of these ...

Home March 09, 2021
Home
News | Hemostasis Management

February 8, 2021 — Teleflex Inc. said it recently completed its acquisition of Z-Medica LLC, an industry-leading ...

Home February 08, 2021
Home
News | Hemostasis Management

August 29, 2019 – Merit Medical Systems Inc. announced the U.S. commercial launch of the PreludeSync Evo radial ...

Home August 29, 2019
Home
Technology | Hemostasis Management

February 1, 2019 — Merit Medical Systems Inc. announced that the PreludeSync Distal Compression Device is now available ...

Home February 01, 2019
Home
Videos | Hemostasis Management

Philippe Genereux, M.D., co-director of the structural heart program at the Gagnon Cardiovascular Institute at ...

Home September 27, 2018
Home
News | Hemostasis Management

August 24, 2016 — Whether severe trauma occurs on the battlefield or the highway, saving lives often comes down to ...

Home August 24, 2016
Home
News | Hemostasis Management

January 6, 2016 — The Medicines Company announced Dec. 18 it has entered into a purchase agreement pursuant to which ...

Home January 06, 2016
Home
Subscribe Now